Avalo Therapeutics, Inc. (AVTX) Earnings Per Share (EPS)
Avalo Therapeutics, Inc. (AVTX) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | $5.04 |
| 2018-12-31 | -$14.40 |
| 2019-12-31 | N/A |
| 2020-12-31 | -$14.92K |
| 2021-12-31 | -$14.34K |
| 2022-12-31 | -$1.06K |
| 2023-12-31 | -$114.00 |
| 2024-12-31 | -$7.94 |
| 2025-12-31 | -$5.84 |
How AVTX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | -$3.74 |
| CELC | Celcuity Inc. | -$3.79 |
| NTLA | Intellia Therapeutics Inc. | -$3.81 |
| ATOS | Atossa Therapeutics Inc. | -$4.04 |
| BHVN | Biohaven Ltd. | -$6.86 |
These are five companies in the same sector as AVTX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Avalo Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("AVTX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AVTX | $19.59 | +0.00% | 0.39M |
| 3 | ||||
| 4 | ||||
| 5 |